⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for cancer of the thyroid

Every month we try and update this database with for cancer of the thyroid cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)NCT03157128
Non-Small Cell ...
Medullary Thyro...
Colon Cancer
Any Solid Tumor
LOXO-292
12 Years - Eli Lilly and Company
Evaluation of Lancet Blood Sampling for Radioiodine Dosimetry in Thyroid CancerNCT02658513
Cancer of the T...
Cancer of Thyro...
Thyroid Cancer
Thyroid Carcino...
Lancet blood sa...
Standard intrav...
18 Years - Royal Surrey County Hospital NHS Foundation Trust
A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) TumorsNCT03899792
Medullary Thyro...
Infantile Myofi...
Infantile Fibro...
Papillary Thyro...
Soft Tissue Sar...
LOXO-292
6 Months - 21 YearsEli Lilly and Company
A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) TumorsNCT03899792
Medullary Thyro...
Infantile Myofi...
Infantile Fibro...
Papillary Thyro...
Soft Tissue Sar...
LOXO-292
6 Months - 21 YearsEli Lilly and Company
A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted TherapyNCT03690388
Differentiated ...
Cabozantinib
Placebo
16 Years - Exelixis
Evaluation of Lancet Blood Sampling for Radioiodine Dosimetry in Thyroid CancerNCT02658513
Cancer of the T...
Cancer of Thyro...
Thyroid Cancer
Thyroid Carcino...
Lancet blood sa...
Standard intrav...
18 Years - Royal Surrey County Hospital NHS Foundation Trust
Biomarkers to Distinguish Benign From Malignant Thyroid NeoplasmNCT01433809
Cancer of the T...
Neoplasms, Thyr...
Thyroid Adenoma
Thyroid Cancer
Thyroid Carcino...
18 Years - 90 YearsMayo Clinic
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: